Beacon Dermatology Inc /ID# 203054

Calgary, Alberta T3E 0B2

0 studies enrolling now · 1 studies all time

What they study most

Psoriasis

Studies at this site

• Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis — Completed